|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD 1.24 billion
|
|
CAGR
(2023-2028)
|
8.23%
|
|
Fastest
Growing Segment
|
Commercial
|
|
Largest
Market
|
North
America
|
Market Overview
Global
Custom Gene Synthesis Service Market has valued at USD
1.24 billion in 2022 and is anticipated to project robust growth in the
forecast period with a CAGR of 8.23% through 2028. The Global Custom Gene
Synthesis Service Market has emerged as a dynamic and rapidly evolving sector
within the life sciences and biotechnology industries. Custom gene synthesis
services involve the artificial creation of DNA sequences, allowing researchers
and biotech companies to design and obtain custom-made genetic material for a
wide range of applications. This market has gained significant traction in
recent years due to the expanding need for synthetic DNA constructs in fields
such as gene therapy, synthetic biology, vaccine development, and genetic
engineering. One of the primary drivers of the custom gene synthesis service
market is the increasing demand for personalized medicine and targeted
therapies. Custom-designed DNA sequences are essential for the development of
gene therapies that can treat genetic disorders and various diseases at the
molecular level. Moreover, the rise of synthetic biology has opened up new
avenues for designing and engineering biological systems, creating a robust
demand for synthetic DNA. Technological advancements, particularly in gene
synthesis techniques like solid-phase synthesis, have improved the accuracy and
efficiency of synthesizing DNA sequences, further boosting the market.
Additionally, falling costs associated with gene synthesis and a growing number
of companies offering these services have made custom gene synthesis more
accessible to researchers and organizations of all sizes.
Key Market Drivers
Rising Demand for Personalized
Medicine
The
rising demand for personalized medicine is a significant driver fueling the
growth of the global custom gene synthesis service market. Personalized
medicine represents a paradigm shift in healthcare, aiming to tailor treatments
to the unique genetic makeup of individual patients. This innovative approach
relies heavily on the precise design and creation of custom DNA sequences,
which are at the core of gene therapy and targeted therapeutics.
Custom
gene synthesis services enable the development of personalized treatments by
providing the necessary genetic material for these advanced therapies. In gene
therapy, custom-designed DNA sequences are used to correct or replace faulty
genes responsible for genetic disorders and diseases. This level of
customization ensures that treatments are highly specific and effective,
minimizing side effects and optimizing patient outcomes.
Furthermore,
the advent of CRISPR-Cas9 gene editing technology has heightened the demand for
custom gene synthesis. CRISPR-Cas9 relies on precisely engineered DNA sequences
to target and modify specific genes with remarkable accuracy. As researchers
explore its potential in treating a wide range of diseases, the need for custom
synthetic DNA constructs becomes paramount.
The
implications of personalized medicine extend beyond genetic disorders. Custom
gene synthesis services play a crucial role in developing treatments for
cancer, autoimmune diseases, and rare conditions. These therapies often require
the creation of custom DNA constructs to target the unique genetic markers of
individual patients, increasing the effectiveness of treatment regimens.
As
the healthcare industry increasingly embraces the concept of personalized
medicine, the demand for custom gene synthesis services is expected to continue
its upward trajectory. This trend is not only transforming the way diseases are
treated but also driving innovation in the field of biotechnology.
Synthetic Biology Advancements
The
global custom gene synthesis service market is experiencing a remarkable boost
from the rapid advancements in synthetic biology. Synthetic biology, an
interdisciplinary field that combines biology, engineering, and computer
science, focuses on designing and engineering biological systems for various
applications. At the heart of these innovations lies the need for precise and
customized DNA sequences, which is where custom gene synthesis services come
into play.
Advancements
in synthetic biology have expanded the horizons of what can be achieved through
genetic engineering. Researchers and biotech companies are now harnessing the
power of custom-designed DNA sequences to create synthetic organisms, engineer
metabolic pathways, and develop novel bioproducts. These applications require
the ability to precisely construct DNA constructs, which has become a driving
force behind the growth of the custom gene synthesis service market.
One
of the key areas where synthetic biology and custom gene synthesis intersect is
in the production of biofuels and biomaterials. By designing DNA sequences that
encode enzymes and metabolic pathways optimized for efficient biofuel
production or the synthesis of biodegradable materials, the potential for
sustainable and eco-friendly solutions is expanding. This not only addresses
environmental concerns but also fuels the demand for custom gene synthesis
services as a vital component of these groundbreaking projects.
Additionally,
the pharmaceutical industry is increasingly turning to synthetic biology to
streamline drug development. Custom gene synthesis services enable the rapid
generation of genetic constructs for producing therapeutic proteins,
antibodies, and vaccines. This accelerates the research and development
process, reducing time-to-market for new drugs and treatments.
Furthermore,
as synthetic biology tools become more sophisticated and accessible, academic
and research institutions are driving demand for custom gene synthesis
services. Researchers in diverse fields, from microbiology to biochemistry,
rely on synthetic DNA constructs to study gene function, create disease models,
and advance our understanding of complex biological systems.
Technological Innovations
Technological
innovations are serving as a driving force behind the growth of the global
custom gene synthesis service market. These innovations are revolutionizing the
field of genetic engineering, making it more efficient, precise, and
cost-effective. As a result, custom gene synthesis services have become
increasingly accessible and attractive to a wide range of industries and
researchers.
One
of the most significant technological advancements in gene synthesis is
solid-phase synthesis. This method involves building DNA sequences one
nucleotide at a time on a solid support, allowing for the creation of longer
and more complex DNA constructs with greater accuracy. Solid-phase synthesis
has significantly improved the efficiency of gene synthesis, reduced errors and
lowering costs, which in turn has spurred the adoption of custom gene synthesis
services.
Another
groundbreaking technology contributing to market growth is high-throughput DNA
synthesis. This approach enables the simultaneous synthesis of thousands of DNA
sequences in parallel, dramatically increasing the throughput and speed of gene
synthesis projects. High-throughput platforms have become essential for
large-scale DNA assembly and the rapid generation of custom DNA constructs,
making them indispensable in industries such as pharmaceuticals and
biotechnology.
Additionally,
advancements in DNA assembly techniques, such as Gibson assembly and Golden
Gate assembly, have streamlined the process of joining DNA fragments together.
These methods are more efficient and versatile than traditional cloning
techniques, allowing for the precise construction of complex genetic
constructs. As a result, researchers and biotech companies are increasingly
turning to custom gene synthesis services for their DNA assembly needs.
Furthermore,
the integration of automation and robotics into gene synthesis workflows has
significantly improved the efficiency and scalability of custom gene synthesis
services. Automated platforms can carry out repetitive tasks with precision and
speed, reducing the risk of human error and ensuring the consistent quality of
synthesized DNA constructs.
Download Free Sample Report
Key Market Challenges
Cost Constraints
The
global custom gene synthesis service market, a burgeoning sector at the intersection
of biotechnology and life sciences, has witnessed impressive growth in recent
years. However, one of the most persistent challenges hampering its widespread
adoption and expansion is cost constraints.
One
of the primary cost-related challenges is the expense of synthesizing DNA,
particularly for longer and more intricate sequences. Despite notable
advancements in technology and process efficiency, the production of synthetic
DNA can still be relatively expensive. This cost can pose a barrier to entry
for researchers, especially those working with limited budgets in academic
institutions or small startups. As a result, these cost constraints can limit
access to custom gene synthesis services, restricting the democratization of
this crucial technology.
Another
cost-related issue is the variability in pricing among different service
providers. The lack of standardized pricing models in the custom gene synthesis
market can make it challenging for customers to compare options and choose the
most cost-effective solution for their specific needs. This variability in
pricing can lead to confusion and uncertainty among potential users, hindering
the market's growth.
Additionally,
the cost of custom gene synthesis services can significantly impact research
budgets and project feasibility. Researchers often require rapid access to
synthesized DNA constructs to advance their studies, but budget constraints can
limit their ability to take full advantage of these services. Delays in
accessing the necessary genetic material can slow down research progress and
affect project timelines, potentially hampering scientific breakthroughs.
Complexity of Large DNA
Constructs
The
global custom gene synthesis service market, which offers tailored DNA
sequences for a myriad of applications, has seen substantial growth. However,
it grapples with a persistent challenge – the complexity of large DNA
constructs. While the promise of custom gene synthesis services is substantial,
the creation of intricate, sizable DNA sequences remains a technical hurdle
that hinders market expansion.
One
of the foremost challenges lies in designing and assembling large and intricate
DNA constructs with precision. As research projects become more ambitious, the
need for longer, complex DNA sequences has become increasingly prevalent. These
sequences may be needed to engineer entire metabolic pathways, create synthetic
organisms, or develop novel bioproducts. However, the intricacies of assembling
such constructs accurately pose significant technical challenges.
Ensuring
the high-fidelity assembly of large genes or synthetic pathways can be a
labor-intensive and time-consuming process. Errors in the sequence assembly can
lead to compromised research results or the ineffectiveness of engineered
biological systems. Researchers and biotech companies often grapple with
optimizing and troubleshooting the synthesis of large DNA constructs, adding
complexity to their projects.
Moreover,
the cost associated with synthesizing large DNA constructs can be prohibitive.
Longer sequences require more resources and time to produce, which can strain
research budgets and project timelines. This financial constraint can
discourage researchers from pursuing projects that necessitate extensive custom
gene synthesis, limiting the market's potential for growth.
Key Market Trends
Emerging Applications in Drug
Discovery
Emerging
applications in drug discovery are playing a pivotal role in boosting the
global custom gene synthesis service market. The pharmaceutical industry has
long been a significant consumer of these services, but recent trends and
innovations are driving even greater demand for customized DNA sequences.
Custom
gene synthesis services are essential for drug discovery and development.
Researchers rely on synthesized DNA constructs to study gene function, validate
potential drug targets, and produce therapeutic proteins. As the drug discovery
process becomes more complex and biologically driven, the need for precision
and customization has grown exponentially.
One
of the emerging applications in drug discovery that is fueling demand for
custom gene synthesis services is CRISPR-Cas9 genome editing. This
revolutionary technology allows researchers to precisely edit and manipulate
genes, making it a powerful tool for identifying and validating potential drug
targets. Custom-designed DNA constructs are essential in guiding CRISPR-Cas9 to
the desired genomic location, enabling accurate gene editing. Furthermore, the
pursuit of personalized medicine in drug development is driving the need for
custom gene synthesis. Custom DNA sequences are used to create patient-specific
models for testing drug responses, ensuring that treatments are tailored to
individual genetic profiles. This approach has the potential to revolutionize
drug efficacy and reduce adverse effects, making it a high-priority area of
research.
Moreover,
as the focus shifts toward rare and orphan diseases, the pharmaceutical
industry is turning to custom gene synthesis services to develop treatments for
conditions with limited patient populations. Customized DNA constructs enable
the production of therapeutic proteins and gene therapies designed specifically
for these niche markets. Additionally, the increasing interest in biologics,
such as monoclonal antibodies and recombinant proteins, is driving demand for
synthetic DNA constructs. These biopharmaceuticals are highly effective in
treating a wide range of diseases, but their production relies on custom gene
synthesis to engineer host cells that can express these complex molecules.
Biotechnology Advancements
Biotechnology
advancements are playing a significant role in boosting the global custom gene
synthesis service market. Custom gene synthesis services, which provide
tailored DNA sequences for various applications, are integral to the progress
and innovation in the biotechnology sector. Several key trends within
biotechnology are contributing to the growing demand for these services.
One
of the primary drivers is the development of novel bioproducts and
biopharmaceuticals. Biotechnology companies are increasingly turning to custom
gene synthesis services to obtain synthetic DNA constructs for the production
of enzymes, antibodies, and other bioproducts. The ability to design and
engineer DNA sequences to optimize the expression of these molecules is
essential for enhancing production yields and the overall efficiency of
biotechnological processes.
Moreover,
biotechnology is at the forefront of therapeutic innovations, particularly in
the field of gene therapy. Custom gene synthesis services are instrumental in
creating the customized genetic material required for gene therapy treatments.
Researchers and biotech firms utilize these services to design and construct
therapeutic DNA sequences that can correct or replace faulty genes, offering
hope for patients with genetic disorders and various diseases. Biotechnology's
emphasis on genetic engineering and synthetic biology further underscores the
importance of custom gene synthesis services. Researchers are engineering
microorganisms to produce biofuels, bio-based materials, and specialty
chemicals. These applications require precise DNA constructs tailored to
specific metabolic pathways, and custom gene synthesis services are
instrumental in providing the required genetic material for these endeavors.
Additionally,
the biotechnology sector's increasing interest in CRISPR-Cas9 genome editing is
driving demand for custom gene synthesis. This revolutionary technology relies
on synthesized DNA constructs to guide the Cas9 enzyme to its target genomic
location, allowing for precise gene editing. As CRISPR-Cas9 applications expand
beyond basic research into therapeutic and industrial contexts, the need for
high-quality, custom-designed DNA sequences continues to grow. Furthermore,
advancements in synthetic biology are propelling the custom gene synthesis
market forward. Synthetic biology seeks to engineer biological systems for
diverse purposes, from creating new pharmaceuticals to designing organisms for
industrial processes.
Segmental Insights
Type Insights
Based on the Type,
the 1001 to 3000 base pairs (bp) emerged as the dominant segment in the global
market for Global Custom Gene Synthesis Service Market in 2022. The CRISPR-Cas9 genome editing
technology, which relies on synthetic DNA constructs as guides for precise gene
editing, often involves sequences within the 1001 to 3000 bp range. Researchers
designing guide RNAs (gRNAs) for specific gene editing applications require
custom DNA constructs that fall within this size category, making it a
significant driver of demand for custom gene synthesis services. Synthetic
biology experiments often require DNA constructs in the 1001 to 3000 bp range.
This size range allows for the creation of synthetic genetic circuits,
engineered microorganisms, and other complex biological systems.
Application Insights
Based on the Application,
the Commercial segment emerged as the dominant player in the global market for
Global Custom Gene Synthesis Service Market in 2022.
Commercial entities
are at the forefront of developing gene therapies and personalized medicine
solutions. These therapies often require custom-designed DNA sequences tailored
to individual patients or specific genetic disorders. Custom gene synthesis services
enable companies to create the genetic material needed for these innovative
medical treatments.
Download Free Sample Report
Regional Insights
North America emerged as the dominant
player in the global Custom Gene Synthesis Service Market in 2022, holding the
largest market share.
North America boasts a highly advanced biotechnology and pharmaceutical sector,
with numerous leading companies, research institutions, and academic centers.
These entities drive substantial demand for custom gene synthesis services to
support their research, drug discovery, and development efforts. Many global
custom gene synthesis service providers have a strong presence in North
America, establishing strategic partnerships and collaborations with local
biotech firms and research institutions. This further bolsters the region's
market dominance.
Recent Developments
- Eurofins
Genomics Blue Heron, a leading biotechnology firm specializing in advanced gene
synthesis, unveiled its In-Vitro Transcription (IVT) Messenger RNA (mRNA)
Synthesis Service on June 29, 2023. This innovative service is meticulously
crafted to provide researchers with a holistic solution for swift, high-quality
mRNA synthesis, tailored to their unique requirements. With versatile
applications, it includes customizable mRNA synthesis capabilities, perfectly
aligned with specific research objectives. This service is adeptly designed for
deployment across diverse fields such as molecular biology, drug discovery,
vaccine development, and gene therapy, catering to the distinct needs of
professionals in these domains.
- On
May 23, 2023, GenScript, a well-established leader in life sciences research
services, introduced its GenPlus Custom Gene Synthesis services. Driven by
GenScript's groundbreaking Miniature Semiconductor Chip (MSC) technology,
GenTitan elevates gene synthesis to unprecedented levels, extending a valuable
resource to researchers globally. This innovation grants scientists in both
academic and industrial sectors the opportunity to access high-throughput
synthetic DNA for their research endeavors.
Key Market Players
- GenScript Biotech Corporation
- Biomatik
Corporation
- ProteoGenix
- Thermo
Fisher Scientific Inc.
- Integrated
DNA Technologies
- Synbio
Technologies
- NZYTech
- Biocompare
- Eurofins
Genomics
- BioCat
GmbH
|
By
Type
|
By
Application
|
By
Region
|
- Below
1000 bp
- 1001
to 3000 bp
- 3001
to 5000 bp
- above
5000 bp
|
- Commercial
- Academic
Research
|
- North
America
- Europe
- Asia
Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the Global Custom Gene Synthesis
Service Market has been segmented into
the following categories, in addition to the industry trends which have also
been detailed below:
- Global Custom Gene Synthesis Service Market, By Type:
o Below 1000 bp
o 1001 to 3000 bp
o 3001 to 5000 bp
o above 5000 bp
- Global Custom Gene Synthesis Service Market, By Application:
o Commercial
o Academic Research
- Global Custom Gene Synthesis Service Market,
By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Custom
Gene Synthesis Service Market.
Available Customizations:
Global Custom Gene Synthesis Service Market report with the given market data, Tech Sci
Research offers customizations according to a company's specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Custom Gene
Synthesis Service Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]